
| 1W | 1M | 6M | 1Y | 5Y | |
|---|---|---|---|---|---|
| Stock | +2.7% | −4.6% | +22.5% | +41.3% | −49.6% |
| SPY | −2.3% | −4.4% | +0.3% | +10.2% | +67.3% |
Historical total returns · Dividends reinvested
Loading…
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.
Is A Medicare Delay The Biggest Risk For DexCom Stock?trefis.com · 1 d ago
Dexcom Announces Upcoming Conference PresentationYahoo Finance · 7 d ago